NO872462L - Fremgangsmaate ved fremstilling av nye, antihypertensive midler. - Google Patents

Fremgangsmaate ved fremstilling av nye, antihypertensive midler.

Info

Publication number
NO872462L
NO872462L NO872462A NO872462A NO872462L NO 872462 L NO872462 L NO 872462L NO 872462 A NO872462 A NO 872462A NO 872462 A NO872462 A NO 872462A NO 872462 L NO872462 L NO 872462L
Authority
NO
Norway
Prior art keywords
acid
solution
agents
oil
salts
Prior art date
Application number
NO872462A
Other languages
English (en)
Norwegian (no)
Other versions
NO872462D0 (no
Inventor
Gary A Flynn
Douglas W Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO872462D0 publication Critical patent/NO872462D0/no
Publication of NO872462L publication Critical patent/NO872462L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO872462A 1986-06-13 1987-06-12 Fremgangsmaate ved fremstilling av nye, antihypertensive midler. NO872462L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87393986A 1986-06-13 1986-06-13

Publications (2)

Publication Number Publication Date
NO872462D0 NO872462D0 (no) 1987-06-12
NO872462L true NO872462L (no) 1987-12-14

Family

ID=25362652

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872462A NO872462L (no) 1986-06-13 1987-06-12 Fremgangsmaate ved fremstilling av nye, antihypertensive midler.

Country Status (11)

Country Link
EP (1) EP0249224A3 (fr)
JP (1) JPS62298592A (fr)
KR (1) KR880000400A (fr)
CN (1) CN87104167A (fr)
AU (1) AU7402387A (fr)
DK (1) DK300287A (fr)
FI (1) FI872612L (fr)
IL (1) IL82812A0 (fr)
NO (1) NO872462L (fr)
PT (1) PT85071A (fr)
ZA (1) ZA874106B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (fr) * 1990-10-18 2002-04-02 Timothy P. Burkholder Derives de mercaptoacetylamide utiles comme inhibiteurs de l'encephalinase et de l'ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
ZA927211B (en) * 1991-09-27 1993-03-24 Merrell Dow Pharma Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE.
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
CA2078758C (fr) * 1991-09-27 2003-12-09 Alan M. Warshawsky Derives de substitution en 2 d'indane-2-mercaptoacetylamide, utiles comme inhibiteurs de l'enkephalinase et de l'enzyme de conversion de l'angiotensine
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
DE69317764T2 (de) * 1992-02-14 1998-07-30 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
PT669936E (pt) * 1992-10-30 2001-04-30 Merrell Pharma Inc Derivados de lactama biciclica de mercaptoacetilamida uteis como inibidores de encefalinase e de ace
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
CA2183314C (fr) * 1994-02-14 1999-08-31 Gary A. Flynn Nouveaux derives bisulfure d'idane-2-mercaptoacetylamides substitues en position 2, utiles comme inhibiteurs de l'encephalinase et de l'enzyme de conversion de l'angiotensine (ace)
JPH09508906A (ja) * 1994-02-14 1997-09-09 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びａｃｅの阻害剤として有用な新規なメルカプトアセチルアミド１，３，４，５−テトラヒドロベンゾ［ｃ］アゼピン−３−オンジスルフィド誘導体類
CA2183313C (fr) * 1994-02-14 2001-01-02 Gary A. Flynn Nouveaux derives de bisulfure d'indane-2-mercaptoacetylamide utiles en tant qu'inhibiteurs de l'encephalinase
WO1995021839A1 (fr) * 1994-02-14 1995-08-17 Merrell Pharmaceuticals Inc. Nouveaux derives bisulfure de mercaptoacetylamides utiles comme inhibiteurs de l'enkephalinase et de l'enzyme de conversion de l'angiotensine (ace)
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
FI963784A0 (fi) * 1994-03-24 1996-09-23 Merrell Pharma Inc Hypokolesteroleemisiä, antiateroskleroottisia ja hypotriglyserideemisiä merkaptoasetyyliamididisulfidijohdannaisia
NZ282568A (en) * 1994-03-24 1997-07-27 Merrell Pharma Inc Use of condensed aminoacetylmercaptobenzazepines in treating elevated cholesterol levels, atherosclerosis, and hypotriglyceridemia
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents

Also Published As

Publication number Publication date
DK300287A (da) 1987-12-14
DK300287D0 (da) 1987-06-12
FI872612A0 (fi) 1987-06-11
KR880000400A (ko) 1988-03-25
NO872462D0 (no) 1987-06-12
FI872612A7 (fi) 1987-12-14
JPS62298592A (ja) 1987-12-25
PT85071A (en) 1987-07-01
CN87104167A (zh) 1988-01-20
EP0249224A2 (fr) 1987-12-16
ZA874106B (en) 1987-12-08
EP0249224A3 (fr) 1989-01-25
IL82812A0 (en) 1987-12-20
AU7402387A (en) 1987-12-17
FI872612L (fi) 1987-12-14

Similar Documents

Publication Publication Date Title
EP0249224A2 (fr) Agent antihypertensif
EP0249223B1 (fr) Agent antihypertensif
US4584294A (en) Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
US4973585A (en) Tricyclic lactams active as antihypertensive agents
US4477464A (en) Hetero-benzazepine derivatives and their pharmaceutical use
EP0061187B1 (fr) Lactames bicycliques comme antihypertenseurs
AU676501B2 (en) Benzo-fused lactams promote release of growth hormone
EP0107095B1 (fr) 1-N-carboxyalkyl-benzolactames utiles comme agents antihypertensifs
EP0079522B1 (fr) Agents antihypertendus N-carboxyméthyl(amidino)-lysyl-prolines
EP0068173B1 (fr) Dérivés de perhydro-1,4-thiazépine-5-one et de perhydro-1,4-thiazocine-5-one, leur procédé de préparation et compositions pharmaceutiques les contenant
US4409146A (en) Substituted caprolactam derivatives as antihypertensives
CH671397A5 (fr)
EP0046289B1 (fr) Dérivés d'oenantholactame substitués comme agents antihypertensifs, leur procédé de préparation, composition pharmaceutique les contenant et produits intermédiaires
US4594341A (en) Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives as antihypertensives
US4617301A (en) Sulfoxide and sulfone derivatives of bicyclic lactams as antihypertensives
FR2467845A1 (fr) Nouveaux derives mercapto-acyles de prolines 4,4-disubstituees et de dehydroprolines 4-substituees, utiles notamment comme medicaments hypotenseurs, compositions therapeutiques et formes pharmaceutiques les contenant, et intermediaires utiles pour leur synthese
US4652641A (en) Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
EP0166353B1 (fr) Benzo-lactames condensés utilisés comme agents antihypertensifs et comme antagonistes de cholecystokinine
EP0081094A1 (fr) Agents antihypertensifs oméga-aminocarboxyméthyl dipeptidiques
US4520021A (en) Substituted caprolactam derivatives as antihypertensives
US4602002A (en) N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents
US4555503A (en) N2 -(Substituted)carboxymethyl-N6 -(substituted)-lysyl-and αε-aminoalkyl)glycyl amino acid antihypertensive agents
KR20070116970A (ko) 안드로겐 조절제
DE3586445T2 (de) Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
EP0049505A2 (fr) Dérivés substitués de caprolactames, procédé pour leur préparation, et composition pharmaceutique les contenant, ainsi que les intermédiaires